Omega-3 (EPA/DHA) Dosage, half-life & reference guide

Also known as Omega-3 · Fish oil · EPA · DHA · EPA/DHA · Krill oil · Algal oil · Icosapent ethyl · Vascepa · Omega 3

Reviewed Evidence: EstablishedPublished by PepVault

The omega-3 fats from oily fish, EPA and DHA, taken as fish, krill or algal oil. They lower triglycerides and are part of every cell membrane and the brain. The big trials were mostly disappointing: 1 g a day did not prevent heart attacks or cancer in healthy older adults, and only a high-dose purified EPA drug cut heart events in high-risk patients.

Studied range
1–4 g
How often
Daily
Evidence
●●● Established
Routes
Oral capsule, Oral liquid

Studied in research — not a recommendation.

How it works.

EPA and DHA are long-chain omega-3 fats from oily fish and algae. They are built into cell membranes, lower triglycerides, and are made into signalling molecules that help resolve inflammation; DHA is a main fat of the brain and retina. Supplements usually carry both, and the ratio matters for the evidence: the one big heart-outcome win was a purified, high-dose EPA drug in people with high triglycerides, while an EPA-plus-DHA product at the same dose showed nothing. In healthy older adults, 1 g a day did not prevent heart disease or cancer. Higher doses raise the risk of atrial fibrillation.

Commonly reported: A fishy aftertaste; some feel joints are less stiff.

Your report

Taken Omega-3 (EPA/DHA)? What did you notice?

One tap to start. About 30 seconds, no account.

A smiling woman with silver hair in a grey training top by a window, holding her phone

PepVault for iPhone

Track Omega-3 (EPA/DHA) in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week.

What to expect in the first 8 weeks

Onset
Weeks (triglycerides; membranes fill over weeks)
Peak effect
Months
Duration
Ongoing; the outcome trials ran about 5 years
  1. Day 1–28RCT

    Read the EPA and DHA, not the oil

    The label's EPA plus DHA line is the dose, not the weight of the oil. The forms differ too: the one heart-outcome win was purified EPA, and a mixed EPA and DHA product at the same 4 g did not repeat it.

    The science

    REDUCE-IT (Bhatt 2019): icosapent ethyl, an EPA ethyl ester, 4 g a day vs placebo, HR 0.75 for the primary end point. STRENGTH (Nicholls 2020): omega-3 carboxylic acids (EPA + DHA) 4 g a day vs corn oil, HR 0.99, stopped for futility. The Vascepa label (Mar 2026) gives 4 g a day.

    Sources
    • Bhatt et al. (REDUCE-IT) (2019)
    • Nicholls et al. (STRENGTH) (2020)
    • FDA label, Vascepa (2026)

    Updated Nov 2026

  2. Day 28–180RCT

    Muscle that ages a little slower

    In a 6-month trial in healthy people aged 60 to 85, fish oil added thigh muscle and grip and leg strength against corn oil, without any change in training. A small trial, but a reason it sits beside creatine in many stacks.

    The science

    Smith 2015 (Am J Clin Nutr): 60 adults aged 60–85, fish-oil n-3 PUFA (n = 40) or corn oil (n = 20) for 6 months, 44 completed; thigh muscle volume +3.6% (95% CI 0.2–7.0%), handgrip +2.3 kg, 1-RM strength +4.0%, isokinetic power +5.6% (P = 0.075).

    Sources
    • Smith et al. (2015)

    Updated Nov 2026

  3. Any dayRCT

    What omega-3 is built on

    Omega-3 has some of the largest supplement trials there are. They show it lowers triglycerides, helps high-risk hearts only as high-dose EPA, slightly raises atrial fibrillation risk at higher doses, and nudged biological-age clocks in one trial. Mice in the NIA's program did not live longer on fish oil.

    The science

    Gencer 2021 (Circulation): 7 RCTs, 81,210 people; atrial fibrillation HR 1.25 (1.07–1.46), HR 1.49 above 1 g a day and 1.12 at or below; HR 1.11 per extra gram. DO-HEALTH (Bischoff-Ferrari 2025, post hoc, 777 adults): 1 g a day for 3 years slowed PhenoAge, GrimAge2 and DunedinPACE (2.9–3.8 months). ITP: fish oil did not extend lifespan (Strong 2016). EFSA: no UL for EPA, DHA or DPA.

    Sources
    • Gencer et al. (2021)
    • Bischoff-Ferrari et al. (DO-HEALTH) (2025)
    • Strong et al. (2016)

    Updated Nov 2026

  4. With Vitamin D3 + K2RCT

    Omega-3, vitamin D and exercise together

    In DO-HEALTH, omega-3 was the piece that slowed the most biological-age clocks, and with vitamin D and home exercise the effect on one clock added up. In VITAL, neither omega-3 nor vitamin D prevented heart disease or cancer.

    The science

    Bischoff-Ferrari 2025: factorial design, 2,000 IU vitamin D, 1 g omega-3, home exercise; additive benefit on PhenoAge. VITAL tested both in a 2×2 factorial design: omega-3 HR 0.92 for major cardiovascular events (Manson 2019).

    Sources
    • Bischoff-Ferrari et al. (DO-HEALTH) (2025)
    • Manson et al. (VITAL) (2019)

    Updated Nov 2026

After week 8

  1. Day 180+RCT

    Hearts: the long trials mostly say no

    For people without heart disease, a daily gram of omega-3 did not prevent heart attacks, strokes or cancer over five years, and pooled trials show little effect on deaths. The clearest benefit is high-dose EPA in people at high risk with high triglycerides.

    The science

    VITAL (Manson 2019): 25,871 adults, 1 g a day, median 5.3 years; major cardiovascular events 386 vs 419, HR 0.92 (0.80–1.06); cancer unchanged. Cochrane (Abdelhamid 2020): 86 RCTs, 162,796 people; all-cause mortality RR 0.97 (0.93–1.01, high certainty), cardiovascular events RR 0.96, coronary heart disease events RR 0.91 (low certainty, NNTB 167).

    Sources
    • Manson et al. (VITAL) (2019)
    • Abdelhamid et al. (Cochrane) (2020)

    Updated Nov 2026

Day 1 is the day you start it.

Large randomized outcome trials, a Cochrane review, an AF meta-analysis, the Vascepa FDA label (Mar 2026), EFSA and the ITP. No trial measured lifespan in people.

Clinical trial data

A typical run.

Run notes

Cycle
Taken daily without breaks; the outcome trials ran about 5 years, the muscle trial 6 months.Community practice — opinions vary. Not a clinical recommendation.
Timing
With a meal, which helps absorption of an oil and eases the aftertaste (common practice). The label for the EPA drug gives 4 g a day, given as 2 g twice daily in REDUCE-IT. The dose that counts is the EPA plus DHA per capsule, not the weight of the oil.
Routes
Oral capsule, Oral liquid
Stacks
Vitamin D3 + K2, Magnesium, Creatine

Track it in the app

Safety.

Common side effects

  • Fishy aftertaste (commonly reported)
  • Stomach upset or loose stools, more at 4 g
  • Slightly more bleeding with blood thinners

Interactions

The Vascepa label names more bleeding alongside antithrombotics (aspirin, clopidogrel, warfarin). Discuss every medication with your clinician, especially blood thinners or a history of atrial fibrillation.

Safety notes

Fish oil is a supplement; EFSA has found no basis to set an upper level for EPA, DHA or DPA. The prescription EPA drug (Vascepa, 4 g a day) carries label warnings for atrial fibrillation or flutter needing hospital care, more with a past history, and for bleeding, more with aspirin, clopidogrel or warfarin; a 2021 meta-analysis found the atrial fibrillation risk rises with dose, about 11% per extra gram a day. At 4 g of an EPA and DHA product, gut side effects were 24.7% against 14.7% on corn oil. With a fish or shellfish allergy, the label notes it is unknown whether allergy risk is higher. Discuss with your clinician.

Questions people ask.

What is Omega-3 (EPA/DHA)?

The omega-3 fats from oily fish, EPA and DHA, taken as fish, krill or algal oil. They lower triglycerides and are part of every cell membrane and the brain. The big trials were mostly disappointing: 1 g a day did not prevent heart attacks or cancer in healthy older adults, and only a high-dose purified EPA drug cut heart events in high-risk patients.

How is Omega-3 (EPA/DHA) dosed in research?

The research range for Omega-3 (EPA/DHA) is 1–4 g, daily. Studied in research — not a recommendation.

How long does Omega-3 (EPA/DHA) last?

The half-life of Omega-3 (EPA/DHA) is not a single number: EPA and DHA are built into cell membranes over weeks of daily intake; not a drug half-life.

What do people report on Omega-3 (EPA/DHA)?

Commonly reported on Omega-3 (EPA/DHA): A fishy aftertaste; some feel joints are less stiff.

Is Omega-3 (EPA/DHA) safe?

The research basis for Omega-3 (EPA/DHA) is established: clinical trials or FDA-approved use exists. Common side effects in the library: fishy aftertaste (commonly reported), stomach upset or loose stools, more at 4 g and slightly more bleeding with blood thinners.

What does Omega-3 (EPA/DHA) stack with?

Common stacks for Omega-3 (EPA/DHA): Vitamin D3 + K2, Magnesium and Creatine.

Track it in the app

Research.

The literature

Search the latest research

Reference.

Cadence

Daily

Half-life

Not a single number: EPA and DHA are built into cell membranes over weeks of daily intake; not a drug half-life

Research basis

●●● Established

Clinical trials or FDA-approved use exists

PepVault for iPhone

Track Omega-3 (EPA/DHA) in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo

Reviewed How we check the library